Alessandro Sette, Dr. Biol. Sci

La Jolla Institute for Allergy and Immunology, La Jolla, CA

Bjoern Peters, PhD

La Jolla Institute for Allergy and Immunology, La Jolla, CA

Erik R. Wambre, PhD, MBE

Benaroya Research Institute, Seattle, WA

Mark Larché, PhD

McMaster University/St. Joseph's Healthcare,
Hamilton, ON, Canada

Tolly Epstein, MD, MS, FAAAAI

University of Cinncinati, Cinncinati, OH

Accredited by

American Academy of Allergy Asthma & Immunology

Course Description

Upon completion of this activity, participants should be able to:
1. Discuss current and future approaches to allergen immunotherapy for asthma and allergic rhinitis
2. Discuss the potential mechanisms by which immunotherapy modulates the immune response to allergens
3. Discuss the durability of immune unresponsiveness induced by allergen immunotherapy

Activity Details

Credit Types:CME / CE
Credit Amount:2.50 Credits
Release Date:2016-Jun-01
Expiration Date:2018-May-31
Estimated Time for Completion:2 hours and 30 minutes
Registration Required:Yes
System Requirements:
Our system supports the two most recent versions of Safari, Google Chrome, and Firefox. Internet Explorer is not recommended.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.